Lacriguard Capsule contains Omega-3 fatty acid 500 mg, a vital polyunsaturated fatty acid known for its beneficial effects on cardiovascular health, cognitive function, and inflammatory conditions. Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), play a crucial role in maintaining cell membrane integrity and modulating inflammatory responses. Lacriguard Capsule is indicated as a dietary supplement to support heart health by reducing triglyceride levels, improving lipid profiles, and potentially lowering the risk of coronary artery disease. Additionally, it may aid in enhancing cognitive performance and visual function, given DHA’s prominence in brain and retinal tissues. The capsule formulation ensures optimal bioavailability and ease of administration. Lacriguard is generally well-tolerated, with minimal adverse effects reported; however, caution is advised in patients with bleeding disorders or those on anticoagulant therapy due to a potential increase in bleeding risk. It is recommended to use Lacriguard Capsule under medical supervision, especially in pregnant or lactating women and individuals with underlying health conditions. Regular intake as part of a balanced diet and healthy lifestyle may contribute to overall wellness and disease prevention.